InterVenn Biosciences Inc.
Overview
InterVenn Biosciences is a biotechnology company that leverages its proprietary glycoproteomics technology to transform the diagnosis and treatment of cancer and other diseases. The company provides novel insights into the biology of glycosylation, offering breakthroughs in predictive, non-invasive tests and therapies.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to InterVenn Biosciences Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this InterVenn Biosciences Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.